Katsuzaki T, Tatemichi N, Takeichi C, Hayakawa S, Hayakawa T, Shibata T, Nakae Y, Naruse S
Department of Clinical Chemistry, Maruko Pharmaceutical Co., Ltd., Kasugai, Japan.
J Clin Lab Anal. 1992;6(3):143-7. doi: 10.1002/jcla.1860060308.
Monoclonal antibodies were raised against human pancreatic stone protein (PSP) and used for one-step enzyme immunoassay (EIA). PSP-S2-5 was employed as the standard in the assay. The assay's measurable range was 25-1,500 ng/ml and within run coefficient of variation was 3.7-6.4%. Analytical recovery of the assay was 101.5 +/- 5.65% (mean +/- SD). The results of experiments in which serum was fractionated by Mono S (cation exchange chromatography) suggested that most of immunoreactive material in human serum is PSP-S2-5. The EIA offers simple, rapid, and specific analysis of serum PSP level for clinical diagnosis.
制备了抗人胰石蛋白(PSP)的单克隆抗体,并将其用于一步酶免疫测定(EIA)。PSP-S2-5用作该测定中的标准品。该测定的可测量范围为25-1500 ng/ml,批内变异系数为3.7-6.4%。该测定的分析回收率为101.5 +/- 5.65%(平均值 +/- 标准差)。用Mono S(阳离子交换色谱法)对血清进行分级分离的实验结果表明,人血清中大部分免疫反应性物质是PSP-S2-5。该EIA为临床诊断提供了简单、快速且特异的血清PSP水平分析方法。